FREE SHIPPING ON ORDERS OVER $200 Now testing for heavy metals and endotoxins ≥98.5% purity Third-party HPLC tested COA on every batch Fast, discreet US shipping
Glutathione 1500mg research peptide vial
Immune

Glutathione

Reduced glutathione (GSH)

A core antioxidant tripeptide studied in redox and detoxification research.

$150

In stock · ships in 1–2 business days

  • ✓ ≥98.5% purity
  • ✓ HPLC + mass-spec tested
  • ✓ Batch COA available
  • ✓ Discreet US shipping
antioxidantredox research

Research Summary

Glutathione is the body’s principal intracellular antioxidant tripeptide, studied in preclinical research for redox balance, detoxification pathways, and oxidative-stress models. For laboratory research use only.

Handling

Store the sealed lyophilized peptide at -20°C, protected from light and moisture. Let the vial reach room temperature before opening to limit condensation. Any further handling should follow your laboratory's own validated procedures, using appropriate protective equipment.

Research overview

Glutathione: what the research shows

Reviewed October 12, 2026 against PubMed and primary sources. For research context only, not medical advice.

What is glutathione?

Glutathione is a tripeptide made of glutamate, cysteine, and glycine. Unlike most peptides, the glutamate is joined to cysteine through its side-chain (gamma) carboxyl group, which is why its systematic name is gamma-L-glutamyl-L-cysteinylglycine [1]. The cysteine thiol is the chemically active part of the molecule.

Glutathione exists in a reduced form (GSH) and an oxidized, disulfide-linked form (GSSG). This product is the reduced form. A 2013 review described GSH as present in all mammalian tissues as the most abundant non-protein thiol, and as a key determinant of redox signaling [2].

Because glutathione is endogenous and central to cell biology, it is used in laboratories both as a subject of study and as a reagent: in redox assays, in enzyme assays for glutathione-dependent enzymes, and as a reference standard. This page describes that research context. It does not cover glutathione products made for human consumption, which are a different category from the material sold here.

Glutathione molecular identity
Structuregamma-L-glutamyl-L-cysteinylglycine (γ-Glu-Cys-Gly), a tripeptide with a gamma peptide bond
FormReduced glutathione (GSH), free thiol
Molecular formulaC10H17N3O6S
Molecular weight307.33 g/mol
CAS number70-18-8
PubChem CID124886
Other namesL-glutathione, reduced glutathione, GSH (PubChem synonyms)

Synthesis and redox chemistry

How cells make glutathione

GSH is synthesized in the cytosol in two enzymatic steps. The 2013 review identified cysteine availability and the activity of the rate-limiting enzyme, glutamate cysteine ligase (GCL), as the key determinants of synthesis, with glutathione synthetase (GS) completing the molecule. Expression of these enzymes is regulated by transcription factors including Nrf2, acting through the antioxidant response element, as well as AP-1 and NF-kappaB [2].

Reduction of oxidants and conjugation of electrophiles

A 2009 review described two main protective chemistries: the elimination of oxidants by reduction, and the elimination of electrophiles by conjugation with GSH [3]. The conjugation reactions are catalyzed by the glutathione transferases, three families of enzymes (cytosolic, mitochondrial, and microsomal) that conjugate electrophilic compounds and also inactivate reactive aldehydes, quinones, epoxides, and hydroperoxides formed during oxidative stress [5].

The GSSG/GSH couple as a redox indicator

A 2001 review proposed using the GSSG/2GSH couple to define the redox environment of cells and tissues. It described this couple as the most abundant redox couple in a cell, showed how its half-cell reduction potential can be estimated with the Nernst equation, and associated more oxidizing potentials with the shift from proliferation to differentiation to apoptosis [4].

Protein S-glutathionylation

Glutathione can also form reversible mixed disulfides with reactive cysteine residues on proteins. A 2007 review described this S-glutathionylation as both a response to mild oxidative or nitrosative stress and a post-translational mechanism for regulating signaling and metabolic proteins under basal conditions [6].

Areas of research

Redox signaling

Research has moved from viewing GSH only as a scavenger toward studying it as a signaling molecule. A 2014 review focused on its role in modulating nitroxidative stress, autophagy, and viral infection, and described its involvement in gene expression, DNA and protein synthesis, signal transduction, proliferation, and apoptosis [7].

Ferroptosis

Glutathione is central to research on ferroptosis, an iron-dependent, non-apoptotic form of cell death. The 2012 study that named ferroptosis reported that the small molecule erastin, like glutamate, inhibits cystine uptake by the cystine/glutamate antiporter (system xc-), which the authors described as creating a void in the antioxidant defenses of the cell and leading to iron-dependent oxidative death. It also identified ferrostatin-1 as an inhibitor of the process [12]. Because cystine supplies the cysteine that limits glutathione synthesis [2], this links ferroptosis research directly to glutathione supply. In a 2014 study across cancer cell lines, one class of ferroptosis-inducing compounds acted by depleting glutathione, which inactivated glutathione peroxidases, while a second class inhibited glutathione peroxidase 4 (GPX4) directly. GPX4 overexpression and knockdown changed sensitivity to 12 ferroptosis inducers but not to 11 compounds with other lethal mechanisms [8].

Disease-model biochemistry

The 2013 review summarized evidence that dysregulation of GSH synthesis contributes to conditions including liver and pulmonary fibrosis, cholestatic liver injury, endotoxemia, and drug-resistant tumor cells [2]. In laboratory work, GSH status is therefore a common readout in models of oxidative and chemical stress.

Glutathione transferase biology

The glutathione transferase review also described roles in the biosynthesis of leukotrienes, prostaglandins, testosterone, and progesterone, and genetic polymorphisms in human transferases studied for their association with disease susceptibility [5].

Measuring glutathione in the lab

Because GSH and GSSG interconvert, many studies report both. A 2006 laboratory method describes a microplate assay in which GSH reacts with DTNB to form a yellow product read at 412 nm, while GSSG is converted back to GSH by glutathione reductase in the presence of NADPH, allowing total and oxidized glutathione to be measured. The authors described it as applicable to blood, plasma, tissues, and cell extracts [9].

Reduced glutathione of known purity is used in work of this kind as a standard and as a substrate for glutathione-dependent enzymes. The 2009 review also discussed methods of assessing GSH status in cells [3].

Research grade versus supplements

Glutathione is sold in many forms, including consumer products. Rejuvatide's glutathione is not one of them. It is a research chemical supplied for in vitro and laboratory use, labeled for research use only, and not intended for human consumption in any form.

This page reports glutathione biochemistry and laboratory findings only. Human studies of consumer glutathione products are outside its scope, and nothing here should be read as a claim about taking glutathione.

Regulatory status

  • FDA drug approval. We found no FDA-approved drug with reduced glutathione as an active ingredient in Drugs@FDA (checked October 12, 2026) [11].
  • Compounding. FDA's list of bulk drug substances nominated for compounding under section 503A (updated May 14, 2026) lists glutathione in category 1, bulk drug substances under evaluation [10]. Category 1 means FDA is still evaluating the nomination; it is not an approval.

Rejuvatide supplies glutathione strictly as a research chemical for in vitro and laboratory use. It is not sold for human or veterinary use.

Testing and quality

A lot-specific certificate of analysis for glutathione is not yet hosted on this page. You can request the certificate for your lot through our COA library, and certificates are supplied exactly as the laboratory issued them.

Browse related compounds in immune and cellular research peptides, or see our FAQ for ordering questions.

Storage of sealed material

Glutathione ships as a dry powder in a sealed vial. For long-term storage, keep sealed vials at -20°C, protected from light and moisture. Allow a vial to reach room temperature before opening to limit condensation. Because the reduced form can oxidize to GSSG [9], handling of opened material and any prepared solutions should follow your laboratory's own validated procedures.

Glutathione FAQ

What is glutathione?

Glutathione is the tripeptide gamma-L-glutamyl-L-cysteinylglycine. It is the most abundant non-protein thiol in mammalian tissues and is studied in redox biology, enzyme research, and cell-death research such as ferroptosis.

What is the difference between GSH and GSSG?

GSH is the reduced form with a free cysteine thiol. GSSG is the oxidized form, two glutathione molecules joined by a disulfide bond. The ratio between them is widely used as an indicator of cellular redox state.

Is this a dietary supplement?

No. Rejuvatide glutathione is a research chemical for laboratory use only. It is not a supplement, food, or drug, and it is not for human consumption.

Is glutathione FDA approved?

We found no FDA-approved drug with reduced glutathione as its active ingredient. FDA lists glutathione in 503A category 1, meaning a compounding nomination is under evaluation, which is not an approval.

What size does Rejuvatide offer?

Glutathione is available as a 1500mg vial.

Is glutathione for human use?

No. Rejuvatide sells glutathione for laboratory research use only. It is not for human or veterinary use, and nothing on this site is medical advice.

References

  1. PubChem. Glutathione, Compound CID 124886. National Library of Medicine. Source
  2. Lu SC. Biochim Biophys Acta. 2013;1830(5):3143-53. PubMed 22995213
  3. Forman HJ, Zhang H, Rinna A. Mol Aspects Med. 2009;30(1-2):1-12. PubMed 18796312
  4. Schafer FQ, Buettner GR. Free Radic Biol Med. 2001;30(11):1191-212. PubMed 11368918
  5. Hayes JD, Flanagan JU, Jowsey IR. Annu Rev Pharmacol Toxicol. 2005;45:51-88. PubMed 15822171
  6. Dalle-Donne I, Rossi R, Giustarini D, et al. Free Radic Biol Med. 2007;43(6):883-98. PubMed 17697933
  7. Aquilano K, Baldelli S, Ciriolo MR. Front Pharmacol. 2014;5:196. PubMed 25206336
  8. Yang WS, SriRamaratnam R, Welsch ME, et al. Cell. 2014;156(1-2):317-331. PubMed 24439385
  9. Rahman I, Kode A, Biswas SK. Nat Protoc. 2006;1(6):3159-65. PubMed 17406579
  10. U.S. Food and Drug Administration. Bulk drug substances nominated for use in compounding under section 503A of the FD&C Act (updated May 14, 2026). Source
  11. U.S. Food and Drug Administration. Drugs@FDA: FDA-approved drugs database (searched October 12, 2026). Source
  12. Dixon SJ, Lemberg KM, Lamprecht MR, et al. Cell. 2012;149(5):1060-72. PubMed 22632970